Need Help?

WGS & RNAseq of paired tumor-normal patients presenting a BRCA2 alteration

Raw data FASTQ files of RNAseq (Stranded mRNA prep Ligation-Illumina on NovaSeq 6000, 100bp paired-end) & WGS (PCR Free Roche KAPA Hyper Prep Library on Illumina Novaseq 6000, 150bp paired-end) for 40 samples corresponding to the matched tumor/normal of 10 patients. Raw data FASTQ files of WGS (PCR Free Roche KAPA Hyper Prep Library on Illumina Novaseq 6000, 150bp paired-end) of the tumor of two additional patients.

Request Access

Institut Curie Data Access Agreement - These terms and conditions govern access to the managed access datasets to which the User Institution has requested access. The User Institution agrees to be bound by these terms and conditions.

Definitions : - Authorised Personnel: The individuals at the User Institution to whom Institut Curie grants access to the Data. This includes the User, the individuals listed in Appendix II and any other individuals for whom the User Institution subsequently requests access to the Data. Details of the initial Authorised Personnel are set out in Appendix II. - Data: The managed access datasets to which the User Institution has requested access. - Data Producers: Institut Curie and the collaborators listed in Appendix I responsible for the development, organisation, and oversight of these Data. - External Collaborator: A collaborator of the User, working for an institution other than the User Institution. - Project: The project for which the User Institution has requested access to these Data. A description of the Project is set out in Appendix II. - Publications: Includes, without limitation, articles published in print journals, electronic journals, reviews, books, posters and other written and verbal presentations of research. - Research Participant: An individual whose data form part of these Data. - Research Purposes: Shall mean research that is seeking to advance the understanding of genetics and genomics, including the treatment of disorders, and work on statistical methods that may be applied to such research. - User: The principal investigator for the Project. - User Institution(s): The Institution that has requested access to the Data. 1. The User Institution agrees to only use these Data for the purpose of the Project (described in Appendix II) and only for Research Purposes. The User Institution further agrees that it will only use these Data for Research Purposes which are within the limitations (if any) set out in Appendix I. 2. The User Institution agrees to preserve, at all times, the confidentiality of these Data. In particular, it undertakes not to use, or attempt to use these Data to compromise or otherwise infringe the confidentiality of information on Research Participants. Without prejudice to the generality of the foregoing, the User Institution agrees to use at least the measures set out in Appendix I to protect these Data. 3. The User Institution agrees to protect the confidentiality of Research Participants in any research papers or publications that they prepare by taking all reasonable care to limit the possibility of identification. 4. The User Institution agrees not to link or combine these Data to other information or archived data available in a way that could re-identify the Research Participants, even if access to that data has been formally granted to the User Institution or is freely available without restriction. 5. The User Institution agrees only to transfer or disclose these Data, in whole or part, or any material derived from these Data, to the Authorised Personnel. Should the User Institution wish to share these Data with an External Collaborator, the External Collaborator must complete a separate application for access to these Data. 6. The User Institution agrees that the Data Producers, and all other parties involved in the creation, funding or protection of these Data: a) make no warranty or representation, express or implied as to the accuracy, quality or comprehensiveness of these Data; b) exclude to the fullest extent permitted by law all liability for actions, claims, proceedings, demands, losses (including but not limited to loss of profit), costs, awards damages and payments made by the Recipient that may arise (whether directly or indirectly) in any way whatsoever from the Recipient’s use of these Data or from the unavailability of, or break in access to, these Data for whatever reason and; c) bear no responsibility for the further analysis or interpretation of these Data. 7. The User Institution agrees to follow the Fort Lauderdale Guidelines (http://www.wellcome.ac.uk/stellent/groups/corporatesite/@policy_communications/documents/web_document/wtd003207.pdf ) and the Toronto Statement (http://www.nature.com/nature/journal/v461/n7261/full/461168a.html). This includes but is not limited to recognising the contribution of the Data Producers and including a proper acknowledgement in all reports or publications resulting from the use of these Data. 8. The User Institution agrees to follow the Publication Policy in Appendix III. This includes respecting the moratorium period for the Data Producers to publish the first peer-reviewed report describing and analysing these Data. 9. The User Institution agrees not to make intellectual property claims on these Data and not to use intellectual property protection in ways that would prevent or block access to, or use of, any element of these Data, or conclusion drawn directly from these Data. 10. The User Institution can elect to perform further research that would add intellectual and resource capital to these data and decide to obtain intellectual property rights on these downstream discoveries. In this case, the User Institution agrees to implement licensing policies that will not obstruct further research and to follow the U.S. National Institutes of Health Best Practices for the Licensing of Genomic Inventions (2005) (https://www.icgc.org/files/daco/NIH_BestPracticesLicensingGenomicInventions_2005_en.pdf ) in conformity with the Organisation for Economic Co-operation and Development Guidelines for the Licensing of the Genetic Inventions (2006) (http://www.oecd.org/science/biotech/36198812.pdf ). 11. The User Institution agrees to destroy/discard the Data held, once it is no longer used for the Project, unless obliged to retain the data for archival purposes in conformity with audit or legal requirements. 12. The User Institution will notify Institut Curie within 30 days of any changes or departures of Authorised Personnel. 13. The User Institution will notify Institut Curie prior to any significant changes to the protocol for the Project. 14. The User Institution will notify Institut Curie as soon as it becomes aware of a breach of the terms or conditions of this agreement. 15. Institut Curie may terminate this agreement by written notice to the User Institution. If this agreement terminates for any reason, the User Institution will be required to destroy any Data held, including copies and backup copies. This clause does not prevent the User Institution from retaining these data for archival purpose in conformity with audit or legal requirements. 16. The User Institution accepts that it may be necessary for the Data Producers to alter the terms of this agreement from time to time. As an example, this may include specific provisions relating to the Data required by Data Producers other than Institut Curie. In the event that changes are required, the Data Producers or their appointed agent will contact the User Institution to inform it of the changes and the User Institution may elect to accept the changes or terminate the agreement. 17. If requested, the User Institution will allow data security and management documentation to be inspected to verify that it is complying with the terms of this agreement. 18. The User Institution agrees to distribute a copy of these terms to the Authorised Personnel. The User Institution will procure that the Authorised Personnel comply with the terms of this agreement. 19. This agreement (and any dispute, controversy, proceedings or claim of whatever nature arising out of this agreement or its formation) shall be construed, interpreted and governed by the laws of France and shall be subject to the exclusive jurisdiction of the French courts. APPENDIX I – DATASET DETAILS APPENDIX II ––PROJECT DETAILS APPENDIX III –– PUBLICATION POLICY

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
EGAS50000000613 Whole Genome Sequencing
EGAS50000000614 RNASeq

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Located in
EGAF50000200615 fastq.gz 1.5 GB
EGAF50000200616 fastq.gz 1.6 GB
EGAF50000200617 fastq.gz 1.7 GB
EGAF50000200618 fastq.gz 1.8 GB
EGAF50000200619 fastq.gz 2.0 GB
EGAF50000200620 fastq.gz 2.1 GB
EGAF50000200621 fastq.gz 1.8 GB
EGAF50000200622 fastq.gz 1.9 GB
EGAF50000200623 fastq.gz 2.0 GB
EGAF50000200624 fastq.gz 2.2 GB
EGAF50000200625 fastq.gz 2.1 GB
EGAF50000200626 fastq.gz 2.2 GB
EGAF50000200627 fastq.gz 1.7 GB
EGAF50000200628 fastq.gz 1.8 GB
EGAF50000200629 fastq.gz 1.7 GB
EGAF50000200630 fastq.gz 1.8 GB
EGAF50000200631 fastq.gz 2.0 GB
EGAF50000200632 fastq.gz 2.2 GB
EGAF50000200633 fastq.gz 2.0 GB
EGAF50000200634 fastq.gz 2.1 GB
EGAF50000200635 fastq.gz 1.8 GB
EGAF50000200636 fastq.gz 2.0 GB
EGAF50000200637 fastq.gz 2.5 GB
EGAF50000200638 fastq.gz 2.6 GB
EGAF50000200639 fastq.gz 2.3 GB
EGAF50000200640 fastq.gz 2.4 GB
EGAF50000200641 fastq.gz 2.1 GB
EGAF50000200642 fastq.gz 2.3 GB
EGAF50000200643 fastq.gz 2.1 GB
EGAF50000200644 fastq.gz 2.3 GB
EGAF50000200645 fastq.gz 2.1 GB
EGAF50000200646 fastq.gz 2.2 GB
EGAF50000200647 fastq.gz 2.0 GB
EGAF50000200648 fastq.gz 2.1 GB
EGAF50000200649 fastq.gz 40.5 GB
EGAF50000200650 fastq.gz 1.8 GB
EGAF50000200651 fastq.gz 1.9 GB
EGAF50000200652 fastq.gz 2.3 GB
EGAF50000200653 fastq.gz 2.4 GB
EGAF50000200654 fastq.gz 1.9 GB
EGAF50000200655 fastq.gz 2.0 GB
EGAF50000200656 fastq.gz 42.8 GB
EGAF50000200657 fastq.gz 32.3 GB
EGAF50000200658 fastq.gz 33.7 GB
EGAF50000200659 fastq.gz 22.2 GB
EGAF50000200660 fastq.gz 23.7 GB
EGAF50000200661 fastq.gz 25.7 GB
EGAF50000200662 fastq.gz 27.2 GB
EGAF50000200663 fastq.gz 22.3 GB
EGAF50000200664 fastq.gz 24.0 GB
EGAF50000200665 fastq.gz 19.8 GB
EGAF50000200666 fastq.gz 21.1 GB
EGAF50000200667 fastq.gz 18.5 GB
EGAF50000200668 fastq.gz 19.7 GB
EGAF50000200669 fastq.gz 24.9 GB
EGAF50000200670 fastq.gz 26.7 GB
EGAF50000200671 fastq.gz 24.6 GB
EGAF50000200672 fastq.gz 25.8 GB
EGAF50000200673 fastq.gz 34.7 GB
EGAF50000200674 fastq.gz 37.0 GB
EGAF50000200675 fastq.gz 23.7 GB
EGAF50000200676 fastq.gz 25.3 GB
EGAF50000200677 fastq.gz 21.8 GB
EGAF50000200678 fastq.gz 22.8 GB
EGAF50000200679 fastq.gz 28.4 GB
EGAF50000200680 fastq.gz 30.0 GB
EGAF50000200681 fastq.gz 26.9 GB
EGAF50000200682 fastq.gz 28.5 GB
EGAF50000200683 fastq.gz 19.4 GB
EGAF50000200684 fastq.gz 20.7 GB
EGAF50000200685 fastq.gz 28.9 GB
EGAF50000200686 fastq.gz 31.0 GB
EGAF50000200687 fastq.gz 22.3 GB
EGAF50000200688 fastq.gz 23.9 GB
EGAF50000200689 fastq.gz 25.0 GB
EGAF50000200690 fastq.gz 26.6 GB
EGAF50000200691 fastq.gz 25.2 GB
EGAF50000200692 fastq.gz 26.5 GB
EGAF50000200693 fastq.gz 27.2 GB
EGAF50000200694 fastq.gz 29.2 GB
EGAF50000200695 fastq.gz 20.8 GB
EGAF50000200696 fastq.gz 22.1 GB
EGAF50000200697 fastq.gz 28.0 GB
EGAF50000200698 fastq.gz 29.9 GB
84 Files (1.2 TB)